Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT00397293
Status:
COMPLETED
Last Update Posted:
2010-08-24
First Post:
2006-11-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Sponsor:
Ascenta Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-07
First Submit QC Date:
None
Study First Post Date:
2006-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-08-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-08-20
Last Update Post Date:
2010-08-24
Last Update Post Date Type:
ESTIMATED